BRAMESTON

This brand name is authorized in Cyprus, Malta, Singapore

Active ingredients

The drug BRAMESTON contains one active pharmaceutical ingredient (API):

1 Bromocriptine UNII 3A64E3G5ZO - BROMOCRIPTINE

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications. Read about Bromocriptine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BRAMESTON Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02CB01	Bromocriptine	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB01
N04BC01	Bromocriptine	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): AA084/07301
Country: SG	Health Sciences Authority	Identifier(s): 09507P